{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:47:53Z","timestamp":1792003673448,"version":"4.4.0"},"reference-count":274,"publisher":"IMR Press","issue":"4","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>The first and second phases of the human microbiome project provided a view of mucosal surfaces and the skin of humans that mapped an abundant and complex ecosystem (microbiota) that is composed of bacteria (bacteriobiota), fungi (mycobiota), viruses (virobiota), enteric phages, archaea, protists, and helminths. Intestinal dysbiosis describes an adverse shift in microbial homeostasis in the gut that enhances intestinal epithelial permeability, translocating toxins that may lead to endotoxemia. Numerous intestinal and extra-intestinal illnesses have been linked to gut dysbiosis, including inflammatory bowel disease, infections, food allergies, asthma, diabetes, obesity, multiple sclerosis, autism, periodontitis, and colorectal cancer. The gut-lung axis is a bidirectional communication network between the lungs and the intestines mediated by bacterial elaborated products (e.g., butyrate), immune cells and neural pathways influencing health and disease at both sites. This review has focused on the gut-lung axis and the role that probiotics, prebiotics and postbiotics may play on the amelioration of respiratory symptoms that may result from viral and\/or bacterial lung infections. Clinicians have for some time focused on treating inflammatory lung disorders such as asthma and chronic obstructive pulmonary disease by encouraging beneficial effects on the intestinal microbiome through the gut\u2013lung axis with orally administered probiotics and pre- and\/or postbiotics. The purpose is to restore gut microbial homeostasis. Developing novel delivery platforms to administer probiotics directly to the airways or as adjunctive systemic modulators is a plausible and increasingly supported hypothesis, with careful strain selection, formulation to preserve viability, targeted delivery, and rigorous safety and efficacy testing before clinical use. It is posited that such adjunctive treatments may significantly influence the lung microbiota epigenome by positively impacting the balance of microorganisms within the lung, restoring eubiosis and consequently health.<\/jats:p>","DOI":"10.31083\/fbl48743","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:29:27Z","timestamp":1777454967000},"source":"Crossref","is-referenced-by-count":1,"title":["The Gut\u2013Lung Axis, Epigenetics and Respiratory Disease"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9229-1820","authenticated-orcid":true,"given":"Alex Seungyeon","family":"Byun","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5362-0671","authenticated-orcid":true,"given":"Philip Chi Lip","family":"Kwok","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-3137","authenticated-orcid":true,"given":"Hak-Kim","family":"Chan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7490-9298","authenticated-orcid":true,"given":"Luis","family":"Vitetta","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Guo J, Wang L, Han N, Yuan C, Yin Y, Wang T, et al. People are an organic unity: Gut-lung axis and pneumonia. Heliyon. 2024; 10: e27822.","DOI":"10.1016\/j.heliyon.2024.e27822"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nature Reviews. Genetics. 2012; 13: 260\u2013270.","DOI":"10.1038\/nrg3182"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"The Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature. 2019; 569: 641\u2013648.","DOI":"10.1038\/s41586-019-1238-8"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Medicine. 2011; 3: 14.","DOI":"10.1186\/gm228"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Refisch A, Sen ZD, Klassert TE, Busch A, Besteher B, Danyeli LV, et al. Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation. Neuropharmacology. 2023; 235: 109568.","DOI":"10.1016\/j.neuropharm.2023.109568"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"O\u2019Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: A paradigm with therapeutic implications. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology. 2016; 38: 1167\u20131176.","DOI":"10.1002\/bies.201600008"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Sheng W, Ji G, Zhang L. The Effect of Lithocholic Acid on the Gut-Liver Axis. Frontiers in Pharmacology. 2022; 13: 910493.","DOI":"10.3389\/fphar.2022.910493"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Ma Y, Yang X, Chatterjee V, Wu MH, Yuan SY. The Gut-Lung Axis in Systemic Inflammation. Role of Mesenteric Lymph as a Conduit. American Journal of Respiratory Cell and Molecular Biology. 2021; 64: 19\u201328.","DOI":"10.1165\/rcmb.2020-0196TR"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Gleason B, Chisari E, Parvizi J. Osteoarthritis Can Also Start in the Gut: The Gut-Joint Axis. Indian Journal of Orthopaedics. 2022; 56: 1150\u20131155.","DOI":"10.1007\/s43465-021-00473-8"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Ma Z, Zuo T, Frey N, Rangrez AY. A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation. Signal Transduction and Targeted Therapy. 2024; 9: 237.","DOI":"10.1038\/s41392-024-01946-6"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011; 473: 174\u2013180.","DOI":"10.1038\/nature09944"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science (New York, N.Y.). 2005; 308: 1635\u20131638.","DOI":"10.1126\/science.1110591"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Grice EA, Segre JA. The human microbiome: our second genome. Annual Review of Genomics and Human Genetics. 2012; 13: 151\u2013170.","DOI":"10.1146\/annurev-genom-090711-163814"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Grice EA, Segre JA. The skin microbiome. Nature Reviews. Microbiology. 2011; 9: 244\u2013253.","DOI":"10.1038\/nrmicro2537"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"B\u00e4umler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016; 535: 85\u201393.","DOI":"10.1038\/nature18849"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Tremaroli V, B\u00e4ckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012; 489: 242\u2013249.","DOI":"10.1038\/nature11552"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Koppel N, Maini Rekdal V, Balskus EP. Chemical transformation of xenobiotics by the human gut microbiota. Science (New York, N.Y.). 2017; 356: eaag2770.","DOI":"10.1126\/science.aag2770"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Marchesi JR, Adams DH, Fava F, Hermes GDA, Hirschfield GM, Hold G, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016; 65: 330\u2013339.","DOI":"10.1136\/gutjnl-2015-309990"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157: 121\u2013141.","DOI":"10.1016\/j.cell.2014.03.011"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Kamada N, Seo SU, Chen GY, N\u00fa\u00f1ez G. Role of the gut microbiota in immunity and inflammatory disease. Nature Reviews. Immunology. 2013; 13: 321\u2013335.","DOI":"10.1038\/nri3430"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Butt\u00f3 LF, Haller D. Dysbiosis in intestinal inflammation: Cause or consequence. International Journal of Medical Microbiology: IJMM. 2016; 306: 302\u2013309.","DOI":"10.1016\/j.ijmm.2016.02.010"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Hill DA, Siracusa MC, Abt MC, Kim BS, Kobuley D, Kubo M, et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nature Medicine. 2012; 18: 538\u2013546.","DOI":"10.1038\/nm.2657"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Jochum L, Stecher B. Label or Concept - What Is a Pathobiont? Trends in Microbiology. 2020; 28: 789\u2013792.","DOI":"10.1016\/j.tim.2020.04.011"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Zeng MY, Inohara N, Nu\u00f1ez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunology. 2017; 10: 18\u201326.","DOI":"10.1038\/mi.2016.75"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes & Development. 2009; 23: 781\u2013783.","DOI":"10.1101\/gad.1787609"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Heard E, Martienssen RA. Transgenerational epigenetic inheritance: myths and mechanisms. Cell. 2014; 157: 95\u2013109.","DOI":"10.1016\/j.cell.2014.02.045"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Atlasi Y, Stunnenberg HG. The interplay of epigenetic marks during stem cell differentiation and development. Nature Reviews. Genetics. 2017; 18: 643\u2013658.","DOI":"10.1038\/nrg.2017.57"},{"key":"ref28","unstructured":"Al Aboud NM, Tupper C, Jialal I. Genetics, Epigenetic Mechanism. StatPearls Publishing: Treasure Island (FL). 2023."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Smith RJ, Liang M, Loe AKH, Yung T, Kim JE, Hudson M, et al. Epigenetic control of cellular crosstalk defines gastrointestinal organ fate and function. Nature Communications. 2023; 14: 497.","DOI":"10.1038\/s41467-023-36228-2"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. The New England Journal of Medicine. 2005; 352: 1967\u20131976.","DOI":"10.1056\/NEJMoa041892"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Pieniawska M, I\u017cykowska K. Role of Histone Deacetylases in T-Cell Development and Function. International Journal of Molecular Sciences. 2022; 23: 7828.","DOI":"10.3390\/ijms23147828"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Mamdani H, Jalal SI. Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope? Frontiers in Cell and Developmental Biology. 2020; 8: 582370.","DOI":"10.3389\/fcell.2020.582370"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. The European Respiratory Journal. 2005; 25: 552\u2013563.","DOI":"10.1183\/09031936.05.00117504"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"B\u00e1rtov\u00e1 E. Epigenetic and gene therapy in human and veterinary medicine. Environmental Epigenetics. 2024; 10: dvae006.","DOI":"10.1093\/eep\/dvae006"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2013; 38: 23\u201338.","DOI":"10.1038\/npp.2012.112"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Adam S, Anteneh H, Hornisch M, Wagner V, Lu J, Radde NE, et al. DNA sequence-dependent activity and base flipping mechanisms of DNMT1 regulate genome-wide DNA methylation. Nature Communications. 2020; 11: 3723.","DOI":"10.1038\/s41467-020-17531-8"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Kumar R, Rao DN. Role of DNA methyltransferases in epigenetic regulation in bacteria. Sub-cellular Biochemistry. 2013; 61: 81\u2013102.","DOI":"10.1007\/978-94-007-4525-4_4"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Scanlon K, Shanahan F, Ross RP, Hill C. Exploring the concept of bacterial memory. Nature Microbiology. 2025; 10: 3049\u20133058.","DOI":"10.1038\/s41564-025-02185-3"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"van Esch BCAM, Porbahaie M, Abbring S, Garssen J, Potaczek DP, Savelkoul HFJ, et al. The Impact of Milk and Its Components on Epigenetic Programming of Immune Function in Early Life and Beyond: Implications for Allergy and Asthma. Frontiers in Immunology. 2020; 11: 2141.","DOI":"10.3389\/fimmu.2020.02141"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Malygin EG, Hattman S. DNA methyltransferases: mechanistic models derived from kinetic analysis. Critical Reviews in Biochemistry and Molecular Biology. 2012; 47: 97\u2013193.","DOI":"10.3109\/10409238.2011.620942"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Rahimi-Kolour H, Eshaghi HS, Shams E, Sanjabi F, Nobili S, Raeisi H, et al. Microbiota-driven epigenetic modifications in gastrointestinal cancer: Implications for pathogenesis and therapeutic strategies. World Journal of Microbiology & Biotechnology. 2025; 41: 288.","DOI":"10.1007\/s11274-025-04457-w"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Wang L, Jiang S, Deng Z, Dedon PC, Chen S. DNA phosphorothioate modification-a new multi-functional epigenetic system in bacteria. FEMS Microbiology Reviews. 2019; 43: 109\u2013122.","DOI":"10.1093\/femsre\/fuy036"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Tong T, Chen S, Wang L, Tang Y, Ryu JY, Jiang S, et al. Occurrence, evolution, and functions of DNA phosphorothioate epigenetics in bacteria. Proceedings of the National Academy of Sciences of the United States of America. 2018; 115: E2988\u2013E2996.","DOI":"10.1073\/pnas.1721916115"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Vitetta L, Bambling M, Strodl E. Probiotics and Commensal Bacteria Metabolites Trigger Epigenetic Changes in the Gut and Influence Beneficial Mood Dispositions. Microorganisms. 2023; 11: 1334.","DOI":"10.3390\/microorganisms11051334"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Yang D, Xing Y, Song X, Qian Y. The impact of lung microbiota dysbiosis on inflammation. Immunology. 2020; 159: 156\u2013166.","DOI":"10.1111\/imm.13139"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Rastogi S, Mohanty S, Sharma S, Tripathi P. Possible role of gut microbes and host\u2019s immune response in gut-lung homeostasis. Frontiers in Immunology. 2022; 13: 954339.","DOI":"10.3389\/fimmu.2022.954339"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Romero MA, Casades\u00fas J. The bacterial epigenome. Nature Reviews. Microbiology. 2020; 18: 7\u201320.","DOI":"10.1038\/s41579-019-0286-2"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Crimi E, Benincasa G, Cirri S, Mutesi R, Faenza M, Napoli C. Clinical epigenetics and multidrug-resistant bacterial infections: host remodelling in critical illness. Epigenetics. 2020; 15: 1021\u20131034.","DOI":"10.1080\/15592294.2020.1748918"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Woo V, Alenghat T. Epigenetic regulation by gut microbiota. Gut Microbes. 2022; 14: 2022407.","DOI":"10.1080\/19490976.2021.2022407"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Bhat MI, Kumari A, Kapila S, Kapila R. Probiotic lactobacilli mediated changes in global epigenetic signatures of human intestinal epithelial cells during Escherichia coli challenge. Annals of Microbiology. 2019; 69: 603\u2013612.","DOI":"10.1007\/s13213-019-01451-0"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"KavianFar A, Taherkhani H, Ahmadi A, Salimi M, Lanjanian H, Masoudi-Nejad A. Restoring the epigenetic landscape of lung microbiome: potential therapeutic approach for chronic respiratory diseases. BMC Pulmonary Medicine. 2024; 24: 2.","DOI":"10.1186\/s12890-023-02789-7"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"St\u00f6lting H, Lloyd CM. Pseudomonas aeruginosa: a pathogen making itself at home. Trends in Immunology. 2022; 43: 497\u2013499.","DOI":"10.1016\/j.it.2022.05.002"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Greenwald MA, Wolfgang MC. The changing landscape of the cystic fibrosis lung environment: From the perspective of Pseudomonas aeruginosa. Current Opinion in Pharmacology. 2022; 65: 102262.","DOI":"10.1016\/j.coph.2022.102262"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Bernardy EE, Raghuram V, Goldberg JB. Staphylococcus aureus and Pseudomonas aeruginosa Isolates from the Same Cystic Fibrosis Respiratory Sample Coexist in Coculture. Microbiology Spectrum. 2022; 10: e0097622.","DOI":"10.1128\/spectrum.00976-22"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Cuthbertson L, Walker AW, Oliver AE, Rogers GB, Rivett DW, Hampton TH, et al. Lung function and microbiota diversity in cystic fibrosis. Microbiome. 2020; 8: 45.","DOI":"10.1186\/s40168-020-00810-3"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Kyung Lee M, Armstrong DA, Hazlett HF, Dessaint JA, Mellinger DL, Aridgides DS, et al. Exposure to extracellular vesicles from Pseudomonas aeruginosa result in loss of DNA methylation at enhancer and DNase hypersensitive site regions in lung macrophages. Epigenetics. 2021; 16: 1187\u20131200.","DOI":"10.1080\/15592294.2020.1853318"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Armstrong DA, Lee MK, Hazlett HF, Dessaint JA, Mellinger DL, Aridgides DS, et al. Extracellular Vesicles from Pseudomonas aeruginosa Suppress MHC-Related Molecules in Human Lung Macrophages. ImmunoHorizons. 2020; 4: 508\u2013519.","DOI":"10.4049\/immunohorizons.2000026"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Faure S, de Santa Barbara P. Molecular embryology of the foregut. Journal of Pediatric Gastroenterology and Nutrition. 2011; 52 Suppl 1: S2\u2013S3.","DOI":"10.1097\/MPG.0b013e3182105a1a"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunology. 2017; 10: 299\u2013306.","DOI":"10.1038\/mi.2016.108"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The Microbiome and the Respiratory Tract. Annual Review of Physiology. 2016; 78: 481\u2013504.","DOI":"10.1146\/annurev-physiol-021115-105238"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Tamari M, Del Bel KL, Ver Heul AM, Zamidar L, Orimo K, Hoshi M, et al. Sensory neurons promote immune homeostasis in the lung. Cell. 2024; 187: 44\u201361.e17.","DOI":"10.1016\/j.cell.2023.11.027"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Ximenez C, Torres J. Development of Microbiota in Infants and its Role in Maturation of Gut Mucosa and Immune System. Archives of Medical Research. 2017; 48: 666\u2013680.","DOI":"10.1016\/j.arcmed.2017.11.007"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Madison A, Kiecolt-Glaser JK. Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition. Current Opinion in Behavioral Sciences. 2019; 28: 105\u2013110.","DOI":"10.1016\/j.cobeha.2019.01.011"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Mohr AE, J\u00e4ger R, Carpenter KC, Kerksick CM, Purpura M, Townsend JR, et al. The athletic gut microbiota. Journal of the International Society of Sports Nutrition. 2020; 17: 24.","DOI":"10.1186\/s12970-020-00353-w"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Dong TS, Gupta A. Influence of Early Life, Diet, and the Environment on the Microbiome. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association. 2019; 17: 231\u2013242.","DOI":"10.1016\/j.cgh.2018.08.067"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Alashkar Alhamwe B, L\u00f3pez JF, Zhernov Y, von Strandmann EP, Karaulov A, Kolahian S, et al. Impact of local human microbiota on the allergic diseases: Organ-organ interaction. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology. 2023; 34: e13976.","DOI":"10.1111\/pai.13976"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Frontiers in Immunology. 2020; 11: 2144.","DOI":"10.3389\/fimmu.2020.02144"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Bernard R, Shilts MH, Strickland BA, Boone HH, Payne DC, Brown RF, et al. The relationship between the intestinal microbiome and body mass index in children with cystic fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society. 2024; 23: 242\u2013251.","DOI":"10.1016\/j.jcf.2023.11.002"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Wypych TP, Marsland BJ. Antibiotics as Instigators of Microbial Dysbiosis: Implications for Asthma and Allergy. Trends in Immunology. 2018; 39: 697\u2013711.","DOI":"10.1016\/j.it.2018.02.008"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2017; 390: 659\u2013668.","DOI":"10.1016\/S0140-6736(17)31281-3"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Korpela K, Salonen A, Virta LJ, Kumpu M, Kekkonen RA, de Vos WM. Lactobacillus rhamnosus GG Intake Modifies Preschool Children\u2019s Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use. PloS One. 2016; 11: e0154012.","DOI":"10.1371\/journal.pone.0154012"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Chunxi L, Haiyue L, Yanxia L, Jianbing P, Jin S. The Gut Microbiota and Respiratory Diseases: New Evidence. Journal of Immunology Research. 2020; 2020: 2340670.","DOI":"10.1155\/2020\/2340670"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Marrella V, Nicchiotti F, Cassani B. Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair. International Journal of Molecular Sciences. 2024; 25: 4051.","DOI":"10.3390\/ijms25074051"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Schroeder BO, B\u00e4ckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nature Medicine. 2016; 22: 1079\u20131089.","DOI":"10.1038\/nm.4185"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Li R, Li J, Zhou X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduction and Targeted Therapy. 2024; 9: 19.","DOI":"10.1038\/s41392-023-01722-y"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Hu Y, Feng Y, Wu J, Liu F, Zhang Z, Hao Y, et al. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients. Frontiers in Cellular and Infection Microbiology. 2019; 9: 90.","DOI":"10.3389\/fcimb.2019.00090"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Luo M, Liu Y, Wu P, Luo DX, Sun Q, Zheng H, et al. Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis. Frontiers in Physiology. 2017; 8: 822.","DOI":"10.3389\/fphys.2017.00822"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Wheatley RM, Caballero JD, van der Schalk TE, De Winter FHR, Shaw LP, Kapel N, et al. Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient. Nature Communications. 2022; 13: 6523.","DOI":"10.1038\/s41467-022-34101-2"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Stokholm J, Blaser MJ, Thorsen J, Rasmussen MA, Waage J, Vinding RK, et al. Maturation of the gut microbiome and risk of asthma in childhood. Nature Communications. 2018; 9: 141.","DOI":"10.1038\/s41467-017-02573-2"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Cassol I, Iba\u00f1ez M, Bustamante JP. Key features and guidelines for the application of microbial alpha diversity metrics. Scientific Reports. 2025; 15: 622.","DOI":"10.1038\/s41598-024-77864-y"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Sasaki M, Suaini NHA, Afghani J, Heye KN, O\u2019Mahony L, Venter C, et al. Systematic review of the association between short-chain fatty acids and allergic diseases. Allergy. 2024; 79: 1789\u20131811.","DOI":"10.1111\/all.16065"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Depner M, Taft DH, Kirjavainen PV, Kalanetra KM, Karvonen AM, Peschel S, et al. Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma. Nature Medicine. 2020; 26: 1766\u20131775.","DOI":"10.1038\/s41591-020-1095-x"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Burrows K, Ngai L, Chiaranunt P, Watt J, Popple S, Forde B, et al. A gut commensal protozoan determines respiratory disease outcomes by shaping pulmonary immunity. Cell. 2025; 188: 316\u2013330.e12.","DOI":"10.1016\/j.cell.2024.11.020"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Begley L, Madapoosi S, Opron K, Ndum O, Baptist A, Rysso K, et al. Gut microbiota relationships to lung function and adult asthma phenotype: a pilot study. BMJ Open Respiratory Research. 2018; 5: e000324.","DOI":"10.1136\/bmjresp-2018-000324"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Wang Z, Lai Z, Zhang X, Huang P, Xie J, Jiang Q, et al. Altered gut microbiome compositions are associated with the severity of asthma. Journal of Thoracic Disease. 2021; 13: 4322\u20134338.","DOI":"10.21037\/jtd-20-2189"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Richardson H, Kewin E, Headley DADL, Hennayake C, Dicker AJ, Chalmers JD. Geographical differences in the airway microbiota of COPD patients across the UK. European Respiratory Journal. 2024; 64: PA3293.","DOI":"10.1183\/13993003.congress-2024.PA3293"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Vieceli T, Tejada S, Martinez-Reviejo R, Pumarola T, Schrenzel J, Waterer GW, et al. Impact of air pollution on respiratory microbiome: A narrative review. Intensive & Critical Care Nursing. 2023; 74: 103336.","DOI":"10.1016\/j.iccn.2022.103336"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Filardo S, Di Pietro M, Protano C, Antonucci A, Vitali M, Sessa R. Impact of Air Pollution on the Composition and Diversity of Human Gut Microbiota in General and Vulnerable Populations: A Systematic Review. Toxics. 2022; 10: 579.","DOI":"10.3390\/toxics10100579"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Sampaio Dotto Fiuza B, Machado de Andrade C, Meirelles PM, Santos da Silva J, de Jesus Silva M, Vila Nova Santana C, et al. Gut microbiome signature and nasal lavage inflammatory markers in young people with asthma. The Journal of Allergy and Clinical Immunology. Global. 2024; 3: 100242.","DOI":"10.1016\/j.jacig.2024.100242"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Aslam R, Herrles L, Aoun R, Pioskowik A, Pietrzyk A. Link between gut microbiota dysbiosis and childhood asthma: Insights from a systematic review. The Journal of Allergy and Clinical Immunology. Global. 2024; 3: 100289.","DOI":"10.1016\/j.jacig.2024.100289"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Kim YC, Sohn KH, Kang HR. Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches. The Korean Journal of Internal Medicine. 2024; 39: 746\u2013758.","DOI":"10.3904\/kjim.2023.451"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Jacobsen HA, Karachalia Sandri A, Weinreich UM, Jess T, Larsen L. Increased risk of obstructive lung disease in inflammatory bowel disease: A population-based cohort study. United European Gastroenterology Journal. 2024; 12: 477\u2013486.","DOI":"10.1002\/ueg2.12527"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Labarca G, Drake L, Horta G, Jantz MA, Mehta HJ, Fernandez-Bussy S, et al. Association between inflammatory bowel disease and chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulmonary Medicine. 2019; 19: 186.","DOI":"10.1186\/s12890-019-0963-y"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Raftery AL, O\u2019Brien CA, Harris NL, Tsantikos E, Hibbs ML. Development of severe colitis is associated with lung inflammation and pathology. Frontiers in Immunology. 2023; 14: 1125260.","DOI":"10.3389\/fimmu.2023.1125260"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Ragnoli B, Cena T, Pochetti P, Pignatti P, Malerba M. Lung Involvement in Patients with Ulcerative Colitis: Relationship between Exhaled Nitric Oxide and Lung Function. Journal of Clinical Medicine. 2024; 13: 354.","DOI":"10.3390\/jcm13020354"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Lai HC, Lin TL, Chen TW, Kuo YL, Chang CJ, Wu TR, et al. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide. Gut. 2022; 71: 309\u2013321.","DOI":"10.1136\/gutjnl-2020-322599"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Chiu YC, Lee SW, Liu CW, Lan TY, Wu LSH. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study. Respiratory Research. 2022; 23: 10.","DOI":"10.1186\/s12931-022-01928-8"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Rotevatn A\u00d8, Eagan TM, Tangedal S, Huseb\u00f8 GR, Ostridge K, Nielsen R. Gut microbiota in chronic obstructive pulmonary disease varies by CT-verified emphysema status. European Clinical Respiratory Journal. 2025; 12: 2470499.","DOI":"10.1080\/20018525.2025.2470499"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nature Communications. 2020; 11: 5886.","DOI":"10.1038\/s41467-020-19701-0"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Du Y, He C, An Y, Huang Y, Zhang H, Fu W, et al. The Role of Short Chain Fatty Acids in Inflammation and Body Health. International Journal of Molecular Sciences. 2024; 25: 7379.","DOI":"10.3390\/ijms25137379"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Dupraz L, Magniez A, Rolhion N, Richard ML, Da Costa G, Touch S, et al. Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal \u03b3\u03b4 T cells. Cell Reports. 2021; 36: 109332.","DOI":"10.1016\/j.celrep.2021.109332"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Ruiz de Morales JMG, Puig L, Daud\u00e9n E, Ca\u00f1ete JD, Pablos JL, Mart\u00edn AO, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmunity Reviews. 2020; 19: 102429.","DOI":"10.1016\/j.autrev.2019.102429"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Yan J, Wu Z, Deng L, Huang C, Jing Y, Chen XY, et al. Comprehensive analysis of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity-A prospective, observational study. Heliyon. 2024; 10: e31512.","DOI":"10.1016\/j.heliyon.2024.e31512"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Rofael SAD, Brown J, Lipman MCI, Lowe DM, Spratt D, Quaderi S, et al. Impact of prophylactic and \u2019rescue pack\u2019 antibiotics on the airway microbiome in chronic lung disease. BMJ Open Respiratory Research. 2023; 10: e001335.","DOI":"10.1136\/bmjresp-2022-001335"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Ananya FN, Ahammed MR, Fahem MM, Kafle S, Viswanathan M, Desai D, et al. Association of Intestinal Microbial Dysbiosis With Chronic Obstructive Pulmonary Disease. Cureus. 2021; 13: e19343.","DOI":"10.7759\/cureus.19343"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Song X, Dou X, Chang J, Zeng X, Xu Q, Xu C. The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease. Gut Microbes. 2024; 16: 2414805.","DOI":"10.1080\/19490976.2024.2414805"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Coffey MJ, Nielsen S, Wemheuer B, Kaakoush NO, Garg M, Needham B, et al. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis. Scientific Reports. 2019; 9: 18593.","DOI":"10.1038\/s41598-019-55028-7"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Price CE, Hampton TH, Valls RA, Barrack KE, O\u2019Toole GA, Madan JC, et al. Development of the intestinal microbiome in cystic fibrosis in early life. MSphere. 2023; 8: e0004623.","DOI":"10.1128\/msphere.00046-23"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Burke DG, Fouhy F, Harrison MJ, Rea MC, Cotter PD, O\u2019Sullivan O, et al. The altered gut microbiota in adults with cystic fibrosis. BMC Microbiology. 2017; 17: 58.","DOI":"10.1186\/s12866-017-0968-8"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Marsh R, Gavillet H, Hanson L, Ng C, Mitchell-Whyte M, Major G, et al. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society. 2022; 21: 506\u2013513.","DOI":"10.1016\/j.jcf.2021.11.014"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Hussan H, Clinton SK, Roberts K, Bailey MT. Fusobacterium\u2019s link to colorectal neoplasia sequenced: A systematic review and future insights. World Journal of Gastroenterology. 2017; 23: 8626\u20138650.","DOI":"10.3748\/wjg.v23.i48.8626"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Zepeda-Rivera M, Minot SS, Bouzek H, Wu H, Blanco-M\u00edguez A, Manghi P, et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature. 2024; 628: 424\u2013432.","DOI":"10.1038\/s41586-024-07182-w"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Young C, Wood HM, Fuentes Balaguer A, Bottomley D, Gallop N, Wilkinson L, et al. Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research. 2021; 27: 2246\u20132254.","DOI":"10.1158\/1078-0432.CCR-20-3807"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Caley LR, Wood HM, Bottomley D, Fuentes Balaguer A, Wilkinson L, Dyson J, et al. The gut microbiota in adults with cystic fibrosis compared to colorectal cancer. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society. 2024; 23: 262\u2013268.","DOI":"10.1016\/j.jcf.2023.12.004"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Birch RJ, Peckham D, Wood HM, Quirke P, Konstant-Hambling R, Brownlee K, et al. The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society. 2023; 22: 499\u2013504.","DOI":"10.1016\/j.jcf.2022.10.001"},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"Kristensen M, Prevaes SMPJ, Kalkman G, Tramper-Stranders GA, Hasrat R, de Winter-de Groot KM, et al. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society. 2020; 19: 553\u2013561.","DOI":"10.1016\/j.jcf.2020.04.007"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Reasoner SA, Bernard R, Waalkes A, Penewit K, Lewis J, Sokolow AG, et al. Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor. mBio. 2024; 15: e0193523.","DOI":"10.1128\/mbio.01935-23"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Marsh R, Santos CD, Yule A, Dellschaft NS, Hoad CL, Ng C, et al. Impact of extended Elexacaftor\/Tezacaftor\/Ivacaftor therapy on the gut microbiome in cystic fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society. 2024; 23: 967\u2013976.","DOI":"10.1016\/j.jcf.2024.05.002"},{"key":"ref119","doi-asserted-by":"publisher","unstructured":"Streibel C, Willers CC, Pusterla O, Bauman G, Stranzinger E, Brabandt B, et al. Effects of elexacaftor\/tezacaftor\/ivacaftor therapy in children with cystic fibrosis - a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society. 2023; 22: 615\u2013622.","DOI":"10.1016\/j.jcf.2022.12.012"},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"Sutharsan S, Dillenhoefer S, Welsner M, Stehling F, Brinkmann F, Burkhart M, et al. Impact of elexacaftor\/tezacaftor\/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry. The Lancet Regional Health. Europe. 2023; 32: 100690.","DOI":"10.1016\/j.lanepe.2023.100690"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"Price CE, Valls RA, Ramsey AR, Loeven NA, Jones JT, Barrack KE, et al. Intestinal Bacteroides modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosis. mBio. 2024; 15: e0314423.","DOI":"10.1128\/mbio.03144-23"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"Paw\u0142owska N, Durda-Masny M, Cofta S, Springer D, Szwed A. Gut Dysbiosis Driven by CFTR Gene Mutations in Cystic Fibrosis Patients: From Genetic Disruption to Multisystem Consequences and Microbiota Modulation. Genes. 2025; 16: 1049.","DOI":"10.3390\/genes16091049"},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"Green N, Chan C, Ooi CY. The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis. Pediatric Pulmonology. 2024; 59 Suppl 1: S70\u2013S80.","DOI":"10.1002\/ppul.26913"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Sol\u00e9-Viol\u00e1n J, L\u00f3pez-Rodr\u00edguez M, et al. 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016. Critical Care (London, England). 2016; 20: 94.","DOI":"10.1186\/s13054-016-1208-6"},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"Farr\u00e9-Maduell E, Casals-Pascual C. The origins of gut microbiome research in Europe: From Escherich to Nissle. Human Microbiome Journal. 2019; 14: 100065. https:\/\/doi.org\/","DOI":"10.1016\/j.humic.2019.100065"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. Disordered microbial communities in asthmatic airways. PloS One. 2010; 5: e8578.","DOI":"10.1371\/journal.pone.0008578"},{"key":"ref127","unstructured":"Heatley RV, Thomas P, Prokipchuk EJ, Gauldie J, Sieniewicz DJ, Bienenstock J. Pulmonary function abnormalities in patients with inflammatory bowel disease. The Quarterly Journal of Medicine. 1982; 51: 241\u2013250."},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Douglas JG, McDonald CF, Leslie MJ, Gillon J, Crompton GK, McHardy GJ. Respiratory impairment in inflammatory bowel disease: does it vary with disease activity? Respiratory Medicine. 1989; 83: 389\u2013394.","DOI":"10.1016\/s0954-6111(89)80070-8"},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, et al. Analysis of the lung microbiome in the \u201chealthy\u201d smoker and in COPD. PloS One. 2011; 6: e16384.","DOI":"10.1371\/journal.pone.0016384"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"de Steenhuijsen Piters WAA, Binkowska J, Bogaert D. Early Life Microbiota and Respiratory Tract Infections. Cell Host & Microbe. 2020; 28: 223\u2013232.","DOI":"10.1016\/j.chom.2020.07.004"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"Vitetta L, Manuel R, Zhou JY, Linnane AW, Hall S, Coulson S. The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures. Pharmaceuticals (Basel, Switzerland). 2014; 7: 954\u2013989.","DOI":"10.3390\/ph7090954"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"van Vliet SJ, den Dunnen J, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. Innate signaling and regulation of Dendritic cell immunity. Current Opinion in Immunology. 2007; 19: 435\u2013440.","DOI":"10.1016\/j.coi.2007.05.006"},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"Evans SE, Xu Y, Tuvim MJ, Dickey BF. Inducible innate resistance of lung epithelium to infection. Annual Review of Physiology. 2010; 72: 413\u2013435.","DOI":"10.1146\/annurev-physiol-021909-135909"},{"key":"ref134","doi-asserted-by":"publisher","unstructured":"Ackerman J. The ultimate social network. Scientific American. 2012; 306: 36\u201343.","DOI":"10.1038\/scientificamerican0612-36"},{"key":"ref135","doi-asserted-by":"publisher","unstructured":"Wu BG, Sulaiman I, Tsay JCJ, Perez L, Franca B, Li Y, et al. Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary T-Helper Cell Type 17 Response that Mitigates Susceptibility to Streptococcus pneumoniae. American Journal of Respiratory and Critical Care Medicine. 2021; 203: 1099\u20131111.","DOI":"10.1164\/rccm.202005-1596OC"},{"key":"ref136","doi-asserted-by":"publisher","unstructured":"Segal LN, Clemente JC, Tsay JCJ, Koralov SB, Keller BC, Wu BG, et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nature Microbiology. 2016; 1: 16031.","DOI":"10.1038\/nmicrobiol.2016.31"},{"key":"ref137","doi-asserted-by":"publisher","unstructured":"Krishnamoorthy N, Khare A, Oriss TB, Raundhal M, Morse C, Yarlagadda M, et al. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nature Medicine. 2012; 18: 1525\u20131530.","DOI":"10.1038\/nm.2896"},{"key":"ref138","doi-asserted-by":"publisher","unstructured":"Verma A, Bhagchandani T, Rai A, Nikita, Sardarni UK, Bhavesh NS, et al. Short-Chain Fatty Acid (SCFA) as a Connecting Link between Microbiota and Gut-Lung Axis-A Potential Therapeutic Intervention to Improve Lung Health. ACS Omega. 2024; 9: 14648\u201314671.","DOI":"10.1021\/acsomega.3c05846"},{"key":"ref139","doi-asserted-by":"publisher","unstructured":"Haak BW, Littmann ER, Chaubard JL, Pickard AJ, Fontana E, Adhi F, et al. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018; 131: 2978\u20132986.","DOI":"10.1182\/blood-2018-01-828996"},{"key":"ref140","doi-asserted-by":"publisher","unstructured":"Yeoh YK, Zuo T, Lui GCY, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021; 70: 698\u2013706.","DOI":"10.1136\/gutjnl-2020-323020"},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Blankestijn JM, Baalbaki N, Beijers RJHCG, Cornelissen MEB, Wiersinga WJ, Abdel-Aziz MI, et al. Exploring Heterogeneity of Fecal Microbiome in Long COVID Patients at 3 to 6 Months After Infection. International Journal of Molecular Sciences. 2025; 26: 1781.","DOI":"10.3390\/ijms26041781"},{"key":"ref142","doi-asserted-by":"publisher","unstructured":"Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, et al. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology. 2022; 162: 548\u2013561.e4.","DOI":"10.1053\/j.gastro.2021.10.013"},{"key":"ref143","doi-asserted-by":"publisher","unstructured":"Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, et al. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2020; 71: 2669\u20132678.","DOI":"10.1093\/cid\/ciaa709"},{"key":"ref144","doi-asserted-by":"publisher","unstructured":"Nagata N, Takeuchi T, Masuoka H, Aoki R, Ishikane M, Iwamoto N, et al. Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications. Gastroenterology. 2023; 164: 272\u2013288.","DOI":"10.1053\/j.gastro.2022.09.024"},{"key":"ref145","doi-asserted-by":"publisher","unstructured":"Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014; 63: 1275\u20131283.","DOI":"10.1136\/gutjnl-2013-304833"},{"key":"ref146","doi-asserted-by":"publisher","unstructured":"Kullberg RFJ, Wikki I, Haak BW, Kauko A, Galenkamp H, Peters-Sengers H, et al. Association between butyrate-producing gut bacteria and the risk of infectious disease hospitalisation: results from two observational, population-based microbiome studies. The Lancet. Microbe. 2024; 5: 100864.","DOI":"10.1016\/S2666-5247(24)00079-X"},{"key":"ref147","doi-asserted-by":"publisher","unstructured":"Liu Y, Chan MTV, Chan FKL, Wu WKK, Ng SC, Zhang L. Lower gut abundance of Eubacterium rectale is linked to COVID-19 mortality. Frontiers in Cellular and Infection Microbiology. 2023; 13: 1249069.","DOI":"10.3389\/fcimb.2023.1249069"},{"key":"ref148","doi-asserted-by":"publisher","unstructured":"Ng SC, Peng Y, Zhang L, Mok CK, Zhao S, Li A, et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut. 2022; 71: 1106\u20131116.","DOI":"10.1136\/gutjnl-2021-326563"},{"key":"ref149","doi-asserted-by":"publisher","unstructured":"Zhang LN, Tan JT, Ng HY, Liao YS, Zhang RQ, Chan KH, et al. Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac. Vaccines. 2024; 12: 365.","DOI":"10.3390\/vaccines12040365"},{"key":"ref150","doi-asserted-by":"publisher","unstructured":"Groves HT, Higham SL, Moffatt MF, Cox MJ, Tregoning JS. Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence. mBio. 2020; 11: e03236\u201319.","DOI":"10.1128\/mBio.03236-19"},{"key":"ref151","doi-asserted-by":"publisher","unstructured":"Schmidt ME, Varga SM. The CD8 T Cell Response to Respiratory Virus Infections. Frontiers in Immunology. 2018; 9: 678.","DOI":"10.3389\/fimmu.2018.00678"},{"key":"ref152","doi-asserted-by":"publisher","unstructured":"Yu AI, Zhao L, Eaton KA, Ho S, Chen J, Poe S, et al. Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis. Cell Reports. 2020; 31: 107471.","DOI":"10.1016\/j.celrep.2020.03.035"},{"key":"ref153","doi-asserted-by":"publisher","unstructured":"Luu M, Weigand K, Wedi F, Breidenbend C, Leister H, Pautz S, et al. Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. Scientific Reports. 2018; 8: 14430.","DOI":"10.1038\/s41598-018-32860-x"},{"key":"ref154","doi-asserted-by":"publisher","unstructured":"Alba C, Aparicio M, Gonz\u00e1lez-Mart\u00ednez F, Gonz\u00e1lez-S\u00e1nchez MI, P\u00e9rez-Moreno J, Toledo Del Castillo B, et al. Nasal and Fecal Microbiota and Immunoprofiling of Infants With and Without RSV Bronchiolitis. Frontiers in Microbiology. 2021; 12: 667832.","DOI":"10.3389\/fmicb.2021.667832"},{"key":"ref155","doi-asserted-by":"publisher","unstructured":"Harding JN, Siefker D, Vu L, You D, DeVincenzo J, Pierre JF, et al. Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity. BMC Microbiology. 2020; 20: 140.","DOI":"10.1186\/s12866-020-01816-5"},{"key":"ref156","doi-asserted-by":"publisher","unstructured":"Russell MM, Leimanis-Laurens ML, Bu S, Kinney GA, Teoh ST, McKee RAL, et al. Loss of Health Promoting Bacteria in the Gastrointestinal Microbiome of PICU Infants with Bronchiolitis: A Single-Center Feasibility Study. Children (Basel, Switzerland). 2022; 9: 114.","DOI":"10.3390\/children9010114"},{"key":"ref157","doi-asserted-by":"publisher","unstructured":"Yagi K, Lukacs NW, Huffnagle GB, Kato H, Asai N. Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses. 2024; 16: 220.","DOI":"10.3390\/v16020220"},{"key":"ref158","doi-asserted-by":"publisher","unstructured":"Stickley SA, Fang ZY, Ambalavanan A, Zhang Y, Zacharias AM, Petersen C, et al. Gene-by-environment interactions modulate the infant gut microbiota in asthma and atopy. The Journal of Allergy and Clinical Immunology. 2025; 156: 433\u2013448.","DOI":"10.1016\/j.jaci.2025.03.018"},{"key":"ref159","doi-asserted-by":"publisher","unstructured":"Yagi K, Asai N, Huffnagle GB, Lukacs NW, Fonseca W. Early-Life Lung and Gut Microbiota Development and Respiratory Syncytial Virus Infection. Frontiers in Immunology. 2022; 13: 877771.","DOI":"10.3389\/fimmu.2022.877771"},{"key":"ref160","doi-asserted-by":"publisher","unstructured":"De Filippis F, Valentino V, Sequino G, Borriello G, Riccardi MG, Pierri B, et al. Exposure to environmental pollutants selects for xenobiotic-degrading functions in the human gut microbiome. Nature Communications. 2024; 15: 4482.","DOI":"10.1038\/s41467-024-48739-7"},{"key":"ref161","doi-asserted-by":"publisher","unstructured":"Cabrera-Rubio R, Calvo C, Alcolea S, Bergia M, Atucha J, Pozo F, et al. Gut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome? Microbiology Spectrum. 2024; 12: e0255623.","DOI":"10.1128\/spectrum.02556-23"},{"key":"ref162","doi-asserted-by":"publisher","unstructured":"Wischmeyer PE, Tang H, Ren Y, Bohannon L, Jiang D, Bergens M, et al. Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial. Clinical Nutrition (Edinburgh, Scotland). 2024; 43: 259\u2013267.","DOI":"10.1016\/j.clnu.2023.11.043"},{"key":"ref163","doi-asserted-by":"publisher","unstructured":"Li Q, Cheng F, Xu Q, Su Y, Cai X, Zeng F, et al. The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients. International Immunopharmacology. 2021; 95: 107531.","DOI":"10.1016\/j.intimp.2021.107531"},{"key":"ref164","doi-asserted-by":"publisher","unstructured":"Sencio V, Barthelemy A, Tavares LP, Machado MG, Soulard D, Cuinat C, et al. Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production. Cell Reports. 2020; 30: 2934\u20132947.e6.","DOI":"10.1016\/j.celrep.2020.02.013"},{"key":"ref165","doi-asserted-by":"publisher","unstructured":"Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, et al. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nature Communications. 2022; 13: 5926.","DOI":"10.1038\/s41467-022-33395-6"},{"key":"ref166","doi-asserted-by":"publisher","unstructured":"Fuentes S, den Hartog G, Nanlohy NM, Wijnands L, Ferreira JA, Nicolaie MA, et al. Associations of faecal microbiota with influenza-like illness in participants aged 60 years or older: an observational study. The Lancet. Healthy Longevity. 2021; 2: e13\u2013e23.","DOI":"10.1016\/S2666-7568(20)30034-9"},{"key":"ref167","doi-asserted-by":"publisher","unstructured":"Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020; 159: 944\u2013955.e8.","DOI":"10.1053\/j.gastro.2020.05.048"},{"key":"ref168","doi-asserted-by":"publisher","unstructured":"Kristensen M, de Steenhuijsen Piters WAA, Wildenbeest J, van Houten MA, Zuurbier RP, Hasrat R, et al. The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children. Cell Reports. Medicine. 2024; 5: 101836.","DOI":"10.1016\/j.xcrm.2024.101836"},{"key":"ref169","doi-asserted-by":"publisher","unstructured":"de Steenhuijsen Piters WAA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal MC, et al. Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. American Journal of Respiratory and Critical Care Medicine. 2016; 194: 1104\u20131115.","DOI":"10.1164\/rccm.201602-0220OC"},{"key":"ref170","doi-asserted-by":"publisher","unstructured":"Yildiz S, Mazel-Sanchez B, Kandasamy M, Manicassamy B, Schmolke M. Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis. Microbiome. 2018; 6: 9.","DOI":"10.1186\/s40168-017-0386-z"},{"key":"ref171","doi-asserted-by":"publisher","unstructured":"Qin N, Zheng B, Yao J, Guo L, Zuo J, Wu L, et al. Influence of H7N9 virus infection and associated treatment on human gut microbiota. Scientific Reports. 2015; 5: 14771.","DOI":"10.1038\/srep14771"},{"key":"ref172","doi-asserted-by":"publisher","unstructured":"Liao Q, Wang F, Zhou W, Liao G, Zhang H, Shu Y, et al. Identification of Causal Relationships between Gut Microbiota and Influenza a Virus Infection in Chinese by Mendelian Randomization. Microorganisms. 2024; 12: 1170.","DOI":"10.3390\/microorganisms12061170"},{"key":"ref173","doi-asserted-by":"publisher","unstructured":"Schaus SR, Vasconcelos Pereira G, Luis AS, Madlambayan E, Terrapon N, Ostrowski MP, et al. Ruminococcus torques is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by Bacteroides thetaiotaomicron. mBio. 2024; 15: e0003924.","DOI":"10.1128\/mbio.00039-24"},{"key":"ref174","doi-asserted-by":"publisher","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clinical Journal of Gastroenterology. 2018; 11: 1\u201310.","DOI":"10.1007\/s12328-017-0813-5"},{"key":"ref175","doi-asserted-by":"publisher","unstructured":"Sencio V, Gallerand A, Gomes Machado M, Deruyter L, Heumel S, Soulard D, et al. Influenza Virus Infection Impairs the Gut\u2019s Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids. Infection and Immunity. 2021; 89: e0073420.","DOI":"10.1128\/IAI.00734-20"},{"key":"ref176","doi-asserted-by":"publisher","unstructured":"Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJTH, de Boer JD, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016; 65: 575\u2013583.","DOI":"10.1136\/gutjnl-2015-309728"},{"key":"ref177","doi-asserted-by":"publisher","unstructured":"Yang W, Ansari AR, Niu X, Zou W, Lu M, Dong L, et al. Interaction between gut microbiota dysbiosis and lung infection as gut-lung axis caused by Streptococcus suis in mouse model. Microbiological Research. 2022; 261: 127047.","DOI":"10.1016\/j.micres.2022.127047"},{"key":"ref178","doi-asserted-by":"publisher","unstructured":"Pavel AB, Glickman JW, Michels JR, Kim-Schulze S, Miller RL, Guttman-Yassky E. Th2\/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality. Frontiers in Genetics. 2021; 12: 706902.","DOI":"10.3389\/fgene.2021.706902"},{"key":"ref179","doi-asserted-by":"publisher","unstructured":"Wei B, Sheng Li C. Changes in Th1\/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease. The Journal of International Medical Research. 2018; 46: 3890\u20133902.","DOI":"10.1177\/0300060518781642"},{"key":"ref180","doi-asserted-by":"publisher","unstructured":"Yazar A, Atis S, Konca K, Pata C, Akbay E, Calikoglu M, et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. The American Journal of Gastroenterology. 2001; 96: 1511\u20131516.","DOI":"10.1111\/j.1572-0241.2001.03748.x"},{"key":"ref181","doi-asserted-by":"publisher","unstructured":"Sencio V, Machado MG, Trottein F. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunology. 2021; 14: 296\u2013304.","DOI":"10.1038\/s41385-020-00361-8"},{"key":"ref182","doi-asserted-by":"publisher","unstructured":"Li N, Dai Z, Wang Z, Deng Z, Zhang J, Pu J, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respiratory Research. 2021; 22: 274.","DOI":"10.1186\/s12931-021-01872-z"},{"key":"ref183","doi-asserted-by":"publisher","unstructured":"Weiss GA, Hennet T. Mechanisms and consequences of intestinal dysbiosis. Cellular and Molecular Life Sciences: CMLS. 2017; 74: 2959\u20132977.","DOI":"10.1007\/s00018-017-2509-x"},{"key":"ref184","doi-asserted-by":"publisher","unstructured":"Stephens M, von der Weid PY. Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner. Gut Microbes. 2020; 11: 421\u2013432.","DOI":"10.1080\/19490976.2019.1629235"},{"key":"ref185","doi-asserted-by":"crossref","unstructured":"Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. Journal of Endotoxin Research. 2000; 6: 205\u2013214.","DOI":"10.1179\/096805100101532063"},{"key":"ref186","doi-asserted-by":"publisher","unstructured":"Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms. 2021; 9: 697.","DOI":"10.3390\/microorganisms9040697"},{"key":"ref187","doi-asserted-by":"publisher","unstructured":"Zhou A, Lei Y, Tang L, Hu S, Yang M, Wu L, et al. Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease. Journal of Bacteriology. 2021; 203: e00454-20.","DOI":"10.1128\/JB.00454-20"},{"key":"ref188","doi-asserted-by":"publisher","unstructured":"Demirci M, Tokman HB, Uysal HK, Demiryas S, Karakullukcu A, Saribas S, et al. Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma. Allergologia et Immunopathologia. 2019; 47: 365\u2013371.","DOI":"10.1016\/j.aller.2018.12.009"},{"key":"ref189","doi-asserted-by":"publisher","unstructured":"Chen YS, Jan RL, Lin YL, Chen HH, Wang JY. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatric Pulmonology. 2010; 45: 1111\u20131120.","DOI":"10.1002\/ppul.21296"},{"key":"ref190","doi-asserted-by":"publisher","unstructured":"Sadrifar S, Abbasi-Dokht T, Forouzandeh S, Malek F, Yousefi B, Salek Farrokhi A, et al. Immunomodulatory effects of probiotic supplementation in patients with asthma: a randomized, double-blind, placebo-controlled trial. Allergy, Asthma, and Clinical Immunology: Official Journal of the Canadian Society of Allergy and Clinical Immunology. 2023; 19: 1.","DOI":"10.1186\/s13223-022-00753-4"},{"key":"ref191","doi-asserted-by":"publisher","unstructured":"Thomsen M, Vemuri R, Huygens F, Clarke S, Vitetta L. An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid. Inflammopharmacology. 2024; 32: 2317\u20132335.","DOI":"10.1007\/s10787-024-01503-1"},{"key":"ref192","doi-asserted-by":"publisher","unstructured":"Smith TJ, Rigassio-Radler D, Denmark R, Haley T, Touger-Decker R. Effect of Lactobacillus rhamnosus LGG\u00ae and Bifidobacterium animalis ssp. lactis BB-12\u00ae on health-related quality of life in college students affected by upper respiratory infections. The British Journal of Nutrition. 2013; 109: 1999\u20132007.","DOI":"10.1017\/S0007114512004138"},{"key":"ref193","doi-asserted-by":"publisher","unstructured":"Berni Canani R, Di Costanzo M, Bedogni G, Amoroso A, Cosenza L, Di Scala C, et al. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow\u2019s milk allergy: 3-year randomized controlled trial. The Journal of Allergy and Clinical Immunology. 2017; 139: 1906\u20131913.e4.","DOI":"10.1016\/j.jaci.2016.10.050"},{"key":"ref194","doi-asserted-by":"publisher","unstructured":"Lazarus RP, John J, Shanmugasundaram E, Rajan AK, Thiagarajan S, Giri S, et al. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants. Vaccine. 2018; 36: 273\u2013279.","DOI":"10.1016\/j.vaccine.2017.07.116"},{"key":"ref195","doi-asserted-by":"publisher","unstructured":"Fangous MS, Alexandre Y, Hymery N, Gouriou S, Arzur D, Blay GL, et al. Lactobacilli intra-tracheal administration protects from Pseudomonas aeruginosa pulmonary infection in mice - a proof of concept. Beneficial Microbes. 2019; 10: 893\u2013900.","DOI":"10.3920\/BM2019.0069"},{"key":"ref196","doi-asserted-by":"publisher","unstructured":"Wu Y, Pei C, Wang X, Wang Y, Huang D, Shi S, et al. Probiotics ameliorates pulmonary inflammation via modulating gut microbiota and rectifying Th17\/Treg imbalance in a rat model of PM2.5 induced lung injury. Ecotoxicology and Environmental Safety. 2022; 244: 114060.","DOI":"10.1016\/j.ecoenv.2022.114060"},{"key":"ref197","doi-asserted-by":"publisher","unstructured":"Ju Z, Pan H, Qu C, Xiao L, Zhou M, Wang Y, et al. Lactobacillus rhamnosus GG ameliorates radiation-induced lung fibrosis via lncRNASNHG17\/PTBP1\/NICD axis modulation. Biology Direct. 2023; 18: 2.","DOI":"10.1186\/s13062-023-00357-x"},{"key":"ref198","doi-asserted-by":"publisher","unstructured":"Alvarez S, Herrero C, Bru E, Perdigon G. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. Journal of Food Protection. 2001; 64: 1768\u20131774.","DOI":"10.4315\/0362-028x-64.11.1768"},{"key":"ref199","doi-asserted-by":"publisher","unstructured":"Khailova L, Baird CH, Rush AA, McNamee EN, Wischmeyer PE. Lactobacillus rhamnosus GG improves outcome in experimental pseudomonas aeruginosa pneumonia: potential role of regulatory T cells. Shock (Augusta, Ga.). 2013; 40: 496\u2013503.","DOI":"10.1097\/SHK.0000000000000066"},{"key":"ref200","doi-asserted-by":"publisher","unstructured":"Zelaya H, Tsukida K, Chiba E, Marranzino G, Alvarez S, Kitazawa H, et al. Immunobiotic lactobacilli reduce viral-associated pulmonary damage through the modulation of inflammation-coagulation interactions. International Immunopharmacology. 2014; 19: 161\u2013173.","DOI":"10.1016\/j.intimp.2013.12.020"},{"key":"ref201","doi-asserted-by":"publisher","unstructured":"Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108: 5354\u20135359.","DOI":"10.1073\/pnas.1019378108"},{"key":"ref202","doi-asserted-by":"publisher","unstructured":"Valentin C, Brito Rodrigues P, Verce M, Delbauve S, La Palombara L, Demaret F, et al. Maternal probiotic exposure enhances CD8 T cell protective neonatal immunity and modulates offspring metabolome to control influenza virus infection. Gut Microbes. 2025; 17: 2442526.","DOI":"10.1080\/19490976.2024.2442526"},{"key":"ref203","doi-asserted-by":"publisher","unstructured":"Tu J, Wang Y, Ye X, Wang Y, Zou Y, Jia L, et al. Gut microbial features may influence antiviral IgG levels after vaccination against viral respiratory infectious diseases: the evidence from two-sample bidirectional mendelian randomization. BMC Infectious Diseases. 2024; 24: 431.","DOI":"10.1186\/s12879-024-09189-0"},{"key":"ref204","doi-asserted-by":"publisher","unstructured":"Lau RI, Su Q, Lau ISF, Ching JYL, Wong MCS, Lau LHS, et al. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. The Lancet. Infectious Diseases. 2024; 24: 256\u2013265.","DOI":"10.1016\/S1473-3099(23)00685-0"},{"key":"ref205","doi-asserted-by":"publisher","unstructured":"Bettocchi S, Comotti A, Elli M, De Cosmi V, Berti C, Alberti I, et al. Probiotics and Fever Duration in Children With Upper Respiratory Tract Infections: A Randomized Clinical Trial. JAMA Network Open. 2025; 8: e250669.","DOI":"10.1001\/jamanetworkopen.2025.0669"},{"key":"ref206","doi-asserted-by":"publisher","unstructured":"Zhang J, Zheng X, Luo W, Sun B. Cross-domain microbiomes: the interaction of gut, lung and environmental microbiota in asthma pathogenesis. Frontiers in Nutrition. 2024; 11: 1346923.","DOI":"10.3389\/fnut.2024.1346923"},{"key":"ref207","doi-asserted-by":"publisher","unstructured":"Ashique S, De Rubis G, Sirohi E, Mishra N, Rihan M, Garg A, et al. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Chemico-biological Interactions. 2022; 368: 110231.","DOI":"10.1016\/j.cbi.2022.110231"},{"key":"ref208","doi-asserted-by":"publisher","unstructured":"Fangous MS, Gosset P, Galakhoff N, Gouriou S, Guilloux CA, Payan C, et al. Priming with intranasal lactobacilli prevents Pseudomonas aeruginosa acute pneumonia in mice. BMC Microbiology. 2021; 21: 195.","DOI":"10.1186\/s12866-021-02254-7"},{"key":"ref209","doi-asserted-by":"publisher","unstructured":"Harata G, He F, Hiruta N, Kawase M, Kubota A, Hiramatsu M, et al. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Letters in Applied Microbiology. 2010; 50: 597\u2013602.","DOI":"10.1111\/j.1472-765X.2010.02844.x"},{"key":"ref210","doi-asserted-by":"publisher","unstructured":"Zelaya H, Tada A, Vizoso-Pinto MG, Salva S, Kanmani P, Ag\u00fcero G, et al. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage. Inflammation Research. 2015; 64: 589\u2013602.","DOI":"10.1007\/s00011-015-0837-6"},{"key":"ref211","doi-asserted-by":"publisher","unstructured":"Park MK, Ngo V, Kwon YM, Lee YT, Yoo S, Cho YH, et al. Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PloS One. 2013; 8: e75368.","DOI":"10.1371\/journal.pone.0075368"},{"key":"ref212","doi-asserted-by":"publisher","unstructured":"Xu R, Hong HA, Khandaker S, Baltazar M, Allehyani N, Beentjes D, et al. Nasal delivery of killed Bacillus subtilis spores protects against influenza, RSV and SARS-CoV-2. Frontiers in Immunology. 2025; 16: 1501907.","DOI":"10.3389\/fimmu.2025.1501907"},{"key":"ref213","doi-asserted-by":"publisher","unstructured":"Naureen F, Shah Y, Rehman M, Chaubey P, Nair AK, Khan J, et al. Inhalable dry powder nano-formulations: advancing lung disease therapy-a review. Front Nanotechnology. 2024; 6: 1403313.","DOI":"10.3389\/fnano.2024.1403313"},{"key":"ref214","doi-asserted-by":"publisher","unstructured":"Chan HW, Chow S, Zhang X, Zhao Y, Tong HHY, Chow SF. Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research. AAPS PharmSciTech. 2023; 24: 98.","DOI":"10.1208\/s12249-023-02559-y"},{"key":"ref215","doi-asserted-by":"publisher","unstructured":"Omidian H, Nokhodchi A, Babanejad N. Dry Powder Inhalers for Delivery of Synthetic Biomolecules. Pharmaceuticals (Basel, Switzerland). 2025; 18: 175.","DOI":"10.3390\/ph18020175"},{"key":"ref216","doi-asserted-by":"publisher","unstructured":"Tran DM, Tran TT, Phung TTB, Bui HT, Nguyen PTT, Vu TT, et al. Nasal-spraying Bacillus spores as an effective symptomatic treatment for children with acute respiratory syncytial virus infection. Scientific Reports. 2022; 12: 12402.","DOI":"10.1038\/s41598-022-16136-z"},{"key":"ref217","doi-asserted-by":"publisher","unstructured":"Bich Phung TT, Van Nguyen AT, Thi Bui H, Hoa Nguyen A, Minh Nguyen H, Hong Le HT, et al. P-111. Promising Efficacy of Nasal-Spraying Bacillus Spore probiotics for Supportive Treatment of Pneumonia in Children with RSV and Bacterial Co-infections. Open Forum Infectious Diseases. 2025; 12, ofae631.318. https:\/\/doi.org\/","DOI":"10.1093\/ofid\/ofae631.318"},{"key":"ref218","doi-asserted-by":"publisher","unstructured":"M\u00e5rtensson A, Nordstr\u00f6m FU, Cervin-Hoberg C, Lindstedt M, Sakellariou C, Cervin A, et al. Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. 2022; 52: 774\u2013783.","DOI":"10.1111\/cea.14098"},{"key":"ref219","doi-asserted-by":"publisher","unstructured":"Endam LM, Alromaih S, Gonzalez E, Madrenas J, Cousineau B, Renteria AE, et al. Intranasal Application of Lactococcus lactis W136 Is Safe in Chronic Rhinosinusitis Patients With Previous Sinus Surgery. Frontiers in Cellular and Infection Microbiology. 2020; 10: 440.","DOI":"10.3389\/fcimb.2020.00440"},{"key":"ref220","doi-asserted-by":"publisher","unstructured":"De Boeck I, van den Broek MFL, Allonsius CN, Spacova I, Wittouck S, Martens K, et al. Lactobacilli Have a Niche in the Human Nose. Cell Reports. 2020; 31: 107674.","DOI":"10.1016\/j.celrep.2020.107674"},{"key":"ref221","doi-asserted-by":"publisher","unstructured":"Liu X, Zhao H, Wong A. Accounting for the health risk of probiotics. Heliyon. 2024; 10: e27908.","DOI":"10.1016\/j.heliyon.2024.e27908"},{"key":"ref222","doi-asserted-by":"publisher","unstructured":"Xu R, Yu Y, Chen T. Exploring the dark side of probiotics to pursue light: Intrinsic and extrinsic risks to be opportunistic pathogens. Current Research in Food Science. 2025; 10: 101044.","DOI":"10.1016\/j.crfs.2025.101044"},{"key":"ref223","doi-asserted-by":"publisher","unstructured":"Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews. Gastroenterology & Hepatology. 2017; 14: 491\u2013502.","DOI":"10.1038\/nrgastro.2017.75"},{"key":"ref224","doi-asserted-by":"publisher","unstructured":"Day RL, Harper AJ, Woods RM, Davies OG, Heaney LM. Probiotics: current landscape and future horizons. Future Science OA. 2019; 5: FSO391.","DOI":"10.4155\/fsoa-2019-0004"},{"key":"ref225","doi-asserted-by":"publisher","unstructured":"Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutrition Research Reviews. 2004; 17: 259\u2013275.","DOI":"10.1079\/NRR200479"},{"key":"ref226","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Food Safety and Applied Nutrition. The declaration of certain isolated or synthetic non-digestible carbohydrates as dietary fiber on nutrition and supplement facts labels: guidance for industry. (2018). Available at: https:\/\/www.fda.gov\/files\/food\/published\/Guidance-for-Industry--The-Declaration-of-Certain-Isolated-or-Synthetic-Non-Digestible-Carbohydrates-as-Dietary-Fiber-on-Nutrition-and-Supplement-Facts-Labels-PDF.pdf (Accessed: 2 November 2025)."},{"key":"ref227","doi-asserted-by":"publisher","unstructured":"Arauzo B, Gonz\u00e1lez-Garcinu\u00f1o \u00c1, Tabernero A, Calzada-Funes J, Lobera MP, Del Valle EMM, et al. Engineering Alginate-Based Dry Powder Microparticles to a Size Suitable for the Direct Pulmonary Delivery of Antibiotics. Pharmaceutics. 2022; 14: 2763.","DOI":"10.3390\/pharmaceutics14122763"},{"key":"ref228","doi-asserted-by":"publisher","unstructured":"Hill M, Twigg M, Sheridan EA, Hardy JG, Elborn JS, Taggart CC, et al. Alginate\/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications. Pharmaceutics. 2019; 11: 379.","DOI":"10.3390\/pharmaceutics11080379"},{"key":"ref229","doi-asserted-by":"publisher","unstructured":"van Koningsbruggen-Rietschel S, Davies JC, Pressler T, Fischer R, MacGregor G, Donaldson SH, et al. Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study. ERJ Open Research. 2020; 6: 00132-2020.","DOI":"10.1183\/23120541.00132-2020"},{"key":"ref230","doi-asserted-by":"publisher","unstructured":"Pritchard MF, Oakley JL, Brilliant CD, Rye PD, Forton J, Doull IJ, et al. Mucin structural interactions with an alginate oligomer mucolytic in cystic fibrosis sputum. Vibrational Spectroscopy. 2019; 103: 102932.","DOI":"10.1016\/j.vibspec.2019.102932"},{"key":"ref231","doi-asserted-by":"publisher","unstructured":"Imran S, Gillis RB, Kok MS, Harding SE, Adams GG. Application and use of Inulin as a tool for therapeutic drug delivery. Biotechnology & Genetic Engineering Reviews. 2012; 28: 33\u201345.","DOI":"10.5661\/bger-28-33"},{"key":"ref232","doi-asserted-by":"publisher","unstructured":"Afinjuomo F, Fouladian P, Parikh A, Barclay TG, Song Y, Garg S. Preparation and Characterization of Oxidized Inulin Hydrogel for Controlled Drug Delivery. Pharmaceutics. 2019; 11: 356.","DOI":"10.3390\/pharmaceutics11070356"},{"key":"ref233","doi-asserted-by":"publisher","unstructured":"Afinjuomo F, Abdella S, Youssef SH, Song Y, Garg S. Inulin and Its Application in Drug Delivery. Pharmaceuticals (Basel, Switzerland). 2021; 14: 855.","DOI":"10.3390\/ph14090855"},{"key":"ref234","doi-asserted-by":"publisher","unstructured":"Boucher E, Plazy C, Le Gouellec A, Toussaint B, Hannani D. Inulin Prebiotic Protects against Lethal Pseudomonas aeruginosa Acute Infection via \u03b3\u03b4 T Cell Activation. Nutrients. 2023; 15: 3037.","DOI":"10.3390\/nu15133037"},{"key":"ref235","doi-asserted-by":"publisher","unstructured":"Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunology. 2015; 8: 80\u201393.","DOI":"10.1038\/mi.2014.44"},{"key":"ref236","doi-asserted-by":"publisher","unstructured":"Yuan G, Wen S, Zhong X, Yang X, Xie L, Wu X, et al. Inulin alleviates offspring asthma by altering maternal intestinal microbiome composition to increase short-chain fatty acids. PloS One. 2023; 18: e0283105.","DOI":"10.1371\/journal.pone.0283105"},{"key":"ref237","doi-asserted-by":"publisher","unstructured":"Halnes I, Baines KJ, Berthon BS, MacDonald-Wicks LK, Gibson PG, Wood LG. Soluble Fibre Meal Challenge Reduces Airway Inflammation and Expression of GPR43 and GPR41 in Asthma. Nutrients. 2017; 9: 57.","DOI":"10.3390\/nu9010057"},{"key":"ref238","doi-asserted-by":"publisher","unstructured":"Jang YO, Lee SH, Choi JJ, Kim DH, Choi JM, Kang MJ, et al. Fecal microbial transplantation and a high fiber diet attenuates emphysema development by suppressing inflammation and apoptosis. Experimental & Molecular Medicine. 2020; 52: 1128\u20131139.","DOI":"10.1038\/s12276-020-0469-y"},{"key":"ref239","doi-asserted-by":"publisher","unstructured":"Eraghieh Farahani H, Pourhajibagher M, Asgharzadeh S, Bahador A. Postbiotics: Novel Modulators of Gut Health, Metabolism, and Their Mechanisms of Action. Probiotics and Antimicrobial Proteins. 2025.  (online ahead of print)","DOI":"10.1007\/s12602-025-10832-8"},{"key":"ref240","doi-asserted-by":"publisher","unstructured":"Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews. Gastroenterology & Hepatology. 2021; 18: 649\u2013667.","DOI":"10.1038\/s41575-021-00440-6"},{"key":"ref241","doi-asserted-by":"publisher","unstructured":"Azeva Z, Belay A, Welelaw E, Haile M. Postbiotics and their biotherapeutic potential for chronic disease and their feature perspective: a review. Frontiers in Microbiomes. 2025; 4: 1489339. https:\/\/doi.org\/org\/","DOI":"10.3389\/frmbi.2025.1489339"},{"key":"ref242","doi-asserted-by":"publisher","unstructured":"Tomosada Y, Chiba E, Zelaya H, Takahashi T, Tsukida K, Kitazawa H, et al. Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection. BMC Immunology. 2013; 14: 40.","DOI":"10.1186\/1471-2172-14-40"},{"key":"ref243","doi-asserted-by":"publisher","unstructured":"Akter S, Park JH, Jung HK. Potential Health-Promoting Benefits of Paraprobiotics, Inactivated Probiotic Cells. Journal of Microbiology and Biotechnology. 2020; 30: 477\u2013481.","DOI":"10.4014\/jmb.1911.11019"},{"key":"ref244","doi-asserted-by":"publisher","unstructured":"Antunes KH, Singanayagam A, Williams L, Faiez TS, Farias A, Jackson MM, et al. Airway-delivered short-chain fatty acid acetate boosts antiviral immunity during rhinovirus infection. The Journal of Allergy and Clinical Immunology. 2023; 151: 447\u2013457.e5.","DOI":"10.1016\/j.jaci.2022.09.026"},{"key":"ref245","doi-asserted-by":"publisher","unstructured":"Antunes KH, Stein RT, Franceschina C, da Silva EF, de Freitas DN, Silveira J, et al. Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis. EBioMedicine. 2022; 77: 103891.","DOI":"10.1016\/j.ebiom.2022.103891"},{"key":"ref246","doi-asserted-by":"publisher","unstructured":"Paparo L, Maglio MA, Cortese M, Bruno C, Capasso M, Punzo E, et al. A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine. Molecules (Basel, Switzerland). 2022; 27: 862.","DOI":"10.3390\/molecules27030862"},{"key":"ref247","doi-asserted-by":"publisher","unstructured":"Zhang W, Zhang Q, Zhu Y, Zhang Y, Xia Y, Wei Z, et al. Rectal administration of butyrate ameliorates pulmonary fibrosis in mice through induction of hepatocyte growth factor in the colon via the HDAC-PPAR\u03b3 pathway. Life Sciences. 2022; 309: 120972.","DOI":"10.1016\/j.lfs.2022.120972"},{"key":"ref248","doi-asserted-by":"publisher","unstructured":"Jiang M, Li Z, Zhang F, Li Z, Xu D, Jing J, et al. Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD). BMC Pulmonary Medicine. 2023; 23: 163.","DOI":"10.1186\/s12890-023-02438-z"},{"key":"ref249","doi-asserted-by":"publisher","unstructured":"Stevens J, Culberson E, Kinder J, Ramiriqui A, Gray J, Bonfield M, et al. Microbiota-derived inosine programs protective CD8+ T cell responses against influenza in newborns. Cell. 2025; 188: 4239\u20134256.e19.","DOI":"10.1016\/j.cell.2025.05.013"},{"key":"ref250","doi-asserted-by":"publisher","unstructured":"Ghorbani P, Santhakumar P, Hu Q, Djiadeu P, Wolever TMS, Palaniyar N, et al. Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth. The European Respiratory Journal. 2015; 46: 1033\u20131045.","DOI":"10.1183\/09031936.00143614"},{"key":"ref251","doi-asserted-by":"publisher","unstructured":"Cait A, Hughes MR, Antignano F, Cait J, Dimitriu PA, Maas KR, et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids. Mucosal Immunology. 2018; 11: 785\u2013795.","DOI":"10.1038\/mi.2017.75"},{"key":"ref252","doi-asserted-by":"publisher","unstructured":"Hildebrand CB, Lichatz R, Pich A, M\u00fchlfeld C, Woltemate S, Vital M, et al. Short-chain fatty acids improve inflamm-aging and acute lung injury in old mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2023; 324: L480\u2013L492.","DOI":"10.1152\/ajplung.00296.2022"},{"key":"ref253","doi-asserted-by":"publisher","unstructured":"Rutting S, Xenaki D, Malouf M, Horvat JC, Wood LG, Hansbro PM, et al. Short-chain fatty acids increase TNF\u03b1-induced inflammation in primary human lung mesenchymal cells through the activation of p38 MAPK. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2019; 316: L157\u2013L174.","DOI":"10.1152\/ajplung.00306.2018"},{"key":"ref254","doi-asserted-by":"publisher","unstructured":"Beran J, \u0160alapov\u00e1 E, \u0160pajdel M, Isoprinosine Study (EWO ISO-2014\/1) Team. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study. BMC Infectious Diseases. 2016; 16: 648.","DOI":"10.1186\/s12879-016-1965-5"},{"key":"ref255","doi-asserted-by":"publisher","unstructured":"C R J, Swain AK, Ganga RT, Halnor D, Avhad A, Khan MS, et al. Efficacy and Safety of Inosine Pranobex in COVID-19 Patients: A Multicenter Phase 3 Randomized Double-Blind, Placebo-Controlled Trial. Advanced Therapeutics. 2022; 2200159.","DOI":"10.1002\/adtp.202200159"},{"key":"ref256","doi-asserted-by":"publisher","unstructured":"Yoshida KI, Bott M. Microbial synthesis of health-promoting inositols. Current Opinion in Biotechnology. 2024; 87: 103114.","DOI":"10.1016\/j.copbio.2024.103114"},{"key":"ref257","doi-asserted-by":"publisher","unstructured":"Kim B, Song A, Son A, Shin Y. Gut microbiota and epigenetic choreography: Implications for human health: A review. Medicine. 2024; 103: e39051.","DOI":"10.1097\/MD.0000000000039051"},{"key":"ref258","doi-asserted-by":"publisher","unstructured":"Kopczy\u0144ska J, Kowalczyk M. The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity. Frontiers in Immunology. 2024; 15: 1380476.","DOI":"10.3389\/fimmu.2024.1380476"},{"key":"ref259","doi-asserted-by":"publisher","unstructured":"Rolando M, Silvestre CD, Gomez-Valero L, Buchrieser C. Bacterial methyltransferases: from targeting bacterial genomes to host epigenetics. MicroLife. 2022; 3: uqac014.","DOI":"10.1093\/femsml\/uqac014"},{"key":"ref260","doi-asserted-by":"publisher","unstructured":"Gao Q, Lu S, Wang Y, He L, Wang M, Jia R, et al. Bacterial DNA methyltransferase: A key to the epigenetic world with lessons learned from proteobacteria. Frontiers in Microbiology. 2023; 14: 1129437.","DOI":"10.3389\/fmicb.2023.1129437"},{"key":"ref261","doi-asserted-by":"publisher","unstructured":"Grabiec AM, Potempa J. Epigenetic regulation in bacterial infections: targeting histone deacetylases. Critical Reviews in Microbiology. 2018; 44: 336\u2013350.","DOI":"10.1080\/1040841X.2017.1373063"},{"key":"ref262","doi-asserted-by":"publisher","unstructured":"Chakradhar S. A curious connection: Teasing apart the link between gut microbes and lung disease. Nature Medicine. 2017; 23: 402\u2013404.","DOI":"10.1038\/nm0417-402"},{"key":"ref263","doi-asserted-by":"publisher","unstructured":"McFarland LV. From yaks to yogurt: the history, development, and current use of probiotics. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2015; 60: S85\u2013S90.","DOI":"10.1093\/cid\/civ054"},{"key":"ref264","doi-asserted-by":"publisher","unstructured":"Du T, Lei A, Zhang N, Zhu C. The Beneficial Role of Probiotic Lactobacillus in Respiratory Diseases. Frontiers in Immunology. 2022; 13: 908010.","DOI":"10.3389\/fimmu.2022.908010"},{"key":"ref265","doi-asserted-by":"publisher","unstructured":"Yuksel N, Gelmez B, Yildiz-Pekoz A. Lung Microbiota: Its Relationship to Respiratory System Diseases and Approaches for Lung-Targeted Probiotic Bacteria Delivery. Molecular Pharmaceutics. 2023; 20: 3320\u20133337.","DOI":"10.1021\/acs.molpharmaceut.3c00323"},{"key":"ref266","doi-asserted-by":"publisher","unstructured":"Villena J, Barbieri N, Salva S, Herrera M, Alvarez S. Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei. Microbiology and Immunology. 2009; 53: 636\u2013646.","DOI":"10.1111\/j.1348-0421.2009.00171.x"},{"key":"ref267","doi-asserted-by":"publisher","unstructured":"Massalha I, Segal A, Moskovitz MT, Yakobson A, Zabit R, Stemmer SM, et al. 76TiP Fecal microbiota transplantation to improve efficacy of immune checkpoint inhibitors in metastatic lung cancer. Journal of Thoracic Oncology. 2023; 18: S84.","DOI":"10.1016\/S1556-0864(23)00330-1"},{"key":"ref268","unstructured":"Massalha I. Fecal microbiota transplantation with immune checkpoint inhibitors in lung cancer. Available at: https:\/\/www.careacross.com\/clinical-trials\/trial\/NCT05502913. NCT identifier: NCT05502913 (Accessed: 4 November 2025)."},{"key":"ref269","doi-asserted-by":"publisher","unstructured":"Mendes de Almeida V, Engel DF, Ricci MF, Cruz CS, Lopes \u00cdS, Alves DA, et al. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms. Gut Microbes. 2023; 15: 2249146.","DOI":"10.1080\/19490976.2023.2249146"},{"key":"ref270","doi-asserted-by":"publisher","unstructured":"Byun AS, Vitetta L, Chan HK, Kwok PCL. Respiratory Delivery of Lacticaseibacillus rhamnosus GG by Vibrating-Mesh and Jet Nebulisation. Pharmaceutics. 2024; 16: 1326.","DOI":"10.3390\/pharmaceutics16101326"},{"key":"ref271","doi-asserted-by":"publisher","unstructured":"Glieca S, Quarta E, Bottari B, Bancalari E, Monica S, Scaltriti E, et al. Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa. International Journal of Antimicrobial Agents. 2024; 63: 107001.","DOI":"10.1016\/j.ijantimicag.2023.107001"},{"key":"ref272","doi-asserted-by":"publisher","unstructured":"Tran TT, Cheow WS, Pu S, Park JW, Hadinoto K. Dry Powder Inhaler Formulation of Lactobacillus rhamnosus GG Targeting Pseudomonas aeruginosa Infection in Bronchiectasis Maintenance Therapy. Pharmaceutics. 2024; 16: 980.","DOI":"10.3390\/pharmaceutics16080980"},{"key":"ref273","doi-asserted-by":"publisher","unstructured":"Nicola T, Wenger N, Xu X, Evans M, Qiao L, Rezonzew G, et al. A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation. Nature Communications. 2024; 15: 7113.","DOI":"10.1038\/s41467-024-51169-0"},{"key":"ref274","doi-asserted-by":"publisher","unstructured":"Chotirmall SH, Bogaert D, Chalmers JD, Cox MJ, Hansbro PM, Huang YJ, et al. Therapeutic Targeting of the Respiratory Microbiome. American Journal of Respiratory and Critical Care Medicine. 2022; 206: 535\u2013544.","DOI":"10.1164\/rccm.202112-2704PP"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/4\/10.31083\/FBL48743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:30:41Z","timestamp":1777455041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/4\/10.31083\/FBL48743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":274,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)01980-5"],"URL":"https:\/\/doi.org\/10.31083\/fbl48743","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"48743"}}